Article
VHL mosaicism can be detected by clinical next-generation sequencing and is not restricted to patients with a mild phenotype.
European journal of human genetics : EJHG - 1 Sept 2014
Coppin Lucie, Grutzmacher Claudine, Crépin Michel, Destailleur Evelyne, Giraud Sophie, Cardot-Bauters Catherine, Porchet Nicole, Pigny Pascal
Abstract excerpt
The identification of Von Hippel-Lindau (VHL) mosaic mutations by conventional Sanger sequencing requires a labour-intensive enrichment step, thus explaining that mosaicism occurrence is underestimated in patients. Nowadays, it is possible to detect mutation in cell sub-populations by next-generation sequencing (NGS). Here, we described a diagnosis strategy using NGS with high coverage in a series of eight...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
